Stay updated on Nivolumab After SIRT for HCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.

Latest updates to the Nivolumab After SIRT for HCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed study descriptions and objectives related to the treatment of hepatocellular carcinoma (HCC) with nivolumab and selective internal radiation therapy (SIRT). Additionally, new information about the study's collaborators and a revision update have been added.SummaryDifference38%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Nivolumab After SIRT for HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.